• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Precision radiation oncology

    Precision radiation oncology

    Journal

    年发文量

    研究主题

    论文(321)

    排序
    1Dosimetric Risk Factors for Therapy‐related Pneumonitis in Patients with Immunotherapy Plus Chemotherapy Concurrent Thoracic Radiotherapy
    Ying Lu, Youjia Wang,Guang Han,Jianping Bi,Guoliang Pi,Xinbin Pan,Vivek Verma,Xiaofang Dai,Jiangqiong Huang,Ying Li

    Abstract Objective Combining immune checkpoint inhibitors (ICIs) with chemoradiotherapy is being actively investigated to improve clinical outcomes; however, this strategy may also increase the risk of treatment‐related toxicities. This multicenter study aimed to identify clinical and dosimetric predictors of treatment‐related pneumonitis (TRP) in this patient population, focusing on modifiable predictors of toxicity. Methods A retrospective review was conducted on 69 patients with lung or esophageal cancer treated at three hospitals. All patients received concurrent ICIs, chemotherapy, and thoracic radiotherapy at a dose of 50–60 Gy (in 2 Gy fractions) using inverse‐planned techniques. TRP was graded according to the Common Terminology Criteria for Adverse Events version 5.0. Logistic regression modeling and receiver operating characteristic (ROC) analysis were employed for statistical evaluation. Results Any‐grade TRP occurred in 56.5% of patients. Grade 2–5 TRP occurred in 30.4%, 8.7%, 1.4%, and 0% of patients, respectively. Age ( p = 0.01; OR = 1.1) and mean lung dose (MLD) ( p = 0.02; OR = 2.4) independently contributed to the risk of any‐grade TRP. Age ( p = 0.03; OR = 1.1) and MLD ( p = 0.04; OR = 1.7) were also identified as risk factors for grade 2+ TRP. Other parameters, such as lung V 5, V 10, V 15, V 20, and V 30 were not significantly associated with TRP. ROC analysis identified 13.6 Gy as the optimal MLD threshold for predicting both any‐grade and grade 2+ TRP. Conclusions MLD and age were associated with a higher risk of TRP in patients receiving concurrent chemoradiotherapy and ICIs. These findings may help inform revisions to lung dose constraints, although validation in large‐scale prospective trials is warranted.

    2026
    引用
    AI阅读
    加入学术空间
    2Implementation and Preliminary Evaluation of a Practical Digital Workflow for Routine Laser‐radiation Field Coincidence Quality Assurance on the CyberKnife M6
    Linzheng Hu, Yongkang Zhao, Chunling Zheng, Jiajun Cai, Yajun Jia, Yi Tao, Yikun Liu, Yin Zhang,Zhitao Dai

    Abstract Purpose To implement and preliminarily evaluate a practical digital acquisition‐and‐analysis workflow for routine laser‐radiation field coincidence quality assurance (QA) on the CyberKnife M6 by integrating multileaf collimator (MLC) QA tool‐based laser reference definition, QA StereoChecker (QASC)‐based external digital image acquisition, and automated analysis with CKQA, an in‐house CyberKnife QA software, and to compare this workflow with clinically realistic film‐based alternatives. Methods Methods a and b were film‐based measurements performed at the perch position. Method a used manual laser marking on film, whereas method b used the central metal marker of the MLC QA tool to define the laser reference. Method c used QASC as an external digital image‐acquisition platform in combination with the MLC QA tool, and method d used film on the same QASC‐based setup as a control. All methods were tested with 10 fixed collimators (5–40 mm). Images were analyzed using ImageJ and CKQA. Mean deviation, standard deviation, root mean square error (RMSE), and pairwise two‐sided exact Wilcoxon signed‐rank tests were used for exploratory comparisons. Results All evaluated workflows achieved submillimeter mean deviations. Across both analysis approaches, the mean deviation ranked consistently in descending order: method a > method b > method d > method c. Under the present experimental conditions, method c yielded the lowest mean deviation and RMSE (0.116 mm and 0.155 mm with CKQA), whereas method a showed the largest deviations. Dataset‐level exact Wilcoxon signed‐rank tests showed that several comparisons involving method a were statistically significant, but statistically significant differences were not uniform across both ImageJ‐ and CKQA‐based comparisons. For comparisons between analysis methods within each workflow, CKQA and ImageJ were not significantly different for methods a and b, whereas CKQA yielded significantly lower deviations than ImageJ for methods c and d ( p < 0.05). Conclusions Laser‐radiation field coincidence testing is an established CyberKnife QA procedure. The present study implemented and preliminarily evaluated a practical digital acquisition‐and‐analysis workflow for this routine task. The workflow combining MLC QA tool‐based laser reference definition, QASC‐based external digital image acquisition, and automated CKQA analysis provided a standardized and less operator‐dependent procedure under the present experimental conditions. Its main value lies in reducing manual marking, film handling, scanning, and subjective image‐analysis steps rather than in introducing a new physical measurement principle. In centers where QASC is not available, the film‐based workflow using the MLC QA tool (method b) may serve as a practical alternative.

    2026
    引用
    AI阅读
    加入学术空间
    3Feasibility of Urethra‐Sparing Ultra‐Hypofractionated Three‐Dose‐Level Radiotherapy for Prostate Cancer with a Dominant Intraprostatic Lesion Abutting the High‐Dose Avoidance Zone
    Annalisa Muscato,Denis La Fauci,Anna Viola,Valentina Zagardo,Gianluca Ferini

    Abstract This planning study evaluated ultra‐hypofractionated three‐dose‐level radiotherapy for prostate cancer with a dominant intraprostatic lesion (DIL) abutting the urethral high‐dose avoidance zone (HDAZ). Ten patients (30 volumetric modulated arc therapy [VMAT] plans) were re‐planned with 25 Gy to the pelvis, 35 Gy to the prostate, and 50 Gy to the DIL in five fractions. All plans achieved coverage while keeping urethral doses below the 90 GyEQD2 threshold and meeting organ‐at‐risk constraints, irrespective of DIL size or HDAZ contact. The findings demonstrate the feasibility of urethra‐sparing with effective DIL dose escalation, even in peri‐HDAZ locations.

    2026
    引用
    AI阅读
    加入学术空间
    4Expert Consensus on Clinical Trial Design Guidelines for FLASH Radiotherapy
    Hui Luo,Chen Cheng,Chengliang Yang,Bing Li,Jiandong Zhang, Jinbo Yue,Zhaoyang Lou, Hui Liu,Jing Cai,Hong Ge

    Abstract In recent years, ultra‐high dose‐rate FLASH radiotherapy (FLASH‐RT) has emerged as a prominent research focus in radiation oncology. A series of preclinical data indicate that FLASH‐RT can achieve tumor‐killing efficacy that is not inferior to that of conventional radiotherapy (CONV‐RT) while significantly reducing radiation damage to normal tissues. This distinctive tissue‐sparing effect is known as the “FLASH effect.” Rapid progress has been made in the clinical translation and application of FLASH‐RT. Against this backdrop, the China Anti‐Cancer Association Radiation Oncology Committee and the Chinese Medical Doctor Association Radiation Oncology Physician Committee gathered a group of experts and compiled the “Expert Consensus on Clinical Trial Design Guidelines for FLASH Radiotherapy” based on the latest domestic and international research advancements. This document summarizes the latest advances in FLASH‐RT and offers practical guidance for its design and translational application in future clinical trials.

    2026
    引用
    AI阅读
    加入学术空间
    5177 Lu‐labeled Amidoxime‐functionalized Biodegradable Microspheres for Transarterial Radioembolization of Hepatocellular Carcinoma
    Xingliang Liu, Gang Wang, Zhenwen Zhao,Haoyu Wang, Hongyu Chen,Xiao Xu, Jingdong Li,Hongjuan Ma

    Abstract Purpose Transarterial radioembolization (TARE) is an important locoregional therapy for hepatocellular carcinoma (HCC). However, clinically used yttrium‐90 ( 90 Y) microspheres are non‐biodegradable and provide limited imaging capability, while biodegradable polymeric microspheres prepared using conventional radiolabeling strategies often exhibit poor radionuclide stability. Experimental design We designed a biodegradable radiometal‐chelating microsphere based on amidoxime‐functionalized polylactic acid microspheres (PLA‐g‐PAO‐Ms) engineered via electron beam‐induced graft polymerization. Results The PLA‐g‐PAO‐Ms exhibited a high Lu 3+ loading capacity (33.83 mg g −1 ) and underwent controlled biodegradation in vitro after approximately 20 d. Cell Counting Kit‐8 (CCK‐8) assays confirmed favorable cytocompatibility, with both LO2 and HepG2 cell viabilities exceeding 90% after 72 h, showing no significant difference from the control group ( p > 0.05); by contrast, free Lu 3+ (50 mg·L −1 ) significantly reduced HepG2 viability to 51.4% ( p < 0.001). In a rat orthotopic liver tumor model, the intra‐arterial administration of 177 Lu‐labeled PLA‐g‐PAO‐Ms ( 177 Lu‐PLA‐g‐PAO‐Ms) resulted in pronounced tumor suppression with sustained in vivo radionuclide retention for at least 14 d. Biodistribution analysis revealed selective tumor accumulation of 8.79 ± 1.74 %ID g −1 , significantly higher than that in normal liver ( 1 ± 0.54 %ID g −1 ) and other organs ( P < 0.001 ), whereas free 177 LuCl 3 showed minimal tumor uptake ( 0.30 ± 0.28 %ID g −1 ) with predominant non‐target organ accumulation. Conclusion These findings suggest that PLA‐g‐PAO‐Ms provide a biodegradable microsphere system capable of stable radiometal incorporation and effective tumor suppression following intra‐arterial administration, offering a promising approach for interventional radionuclide therapy for HCC.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 321 篇论文

    高被引作者

    作者引用发文
    Radhe Mohan2034
    Mark N Gaze1191
    Ricky A. Sharma1191
    Bandula Steve1191
    Laura Beaton1191
    Fada Guan10017
    Qiong Chen611
    Peiliang Quan611
    Meng Zhang611
    XiBin Sun611

    高产作者

    作者引用发文
    Fada Guan10017
    Zhitao Dai5111
    Jinbo Yue198
    Jinming Yu247
    Hong Ge207
    Yong Yin347
    Jian Zhu136
    Jing Cai235
    Qingtao Qiu195
    Shuanghu Yuan265

    相关期刊

    Medical dosimetry : official journal of the American Association of Medical Dosimetrists
    Clinical oncology
    Cancer/Radiothérapie
    Radiation oncology (London, England)
    Journal of radiosurgery and SBRT
    International journal of particle therapy
    Radiation Oncology Journal
    Journal of Radiotherapy in Practice
    Cancer Radiotherapie
    Precision Radiation Oncology